AbbVie Gross Carrying Amount decreased by 0.1% to $89.52B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.5%, from $89.99B to $89.52B. Over 5 years (FY 2020 to FY 2025), Gross Carrying Amount shows relatively stable performance with a -1.3% CAGR.
Higher values indicate significant investment in intellectual property or acquisitions, while stability suggests a consistent asset base.
The total historical cost of intangible assets with a defined useful life, such as patents, customer relationships, or s...
Standard across capital-intensive industries; peers with high M&A activity typically show larger balances.
other_finite_lived_intangible_assets_gross| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $96.26B | $96.37B | $97.43B | $97.30B | $96.93B | $95.80B | $96.17B | $96.10B | $96.18B | $84.79B | $83.33B | $90.54B | $89.81B | $90.04B | $89.74B | $89.99B | $90.50B | $89.48B | $89.59B | $89.52B |
| QoQ Change | — | +0.1% | +1.1% | -0.1% | -0.4% | -1.2% | +0.4% | -0.1% | +0.1% | -11.8% | -1.7% | +8.6% | -0.8% | +0.3% | -0.3% | +0.3% | +0.6% | -1.1% | +0.1% | -0.1% |
| YoY Change | — | — | — | — | +0.7% | -0.6% | -1.3% | -1.2% | -0.8% | -11.5% | -13.4% | -5.8% | -6.6% | +6.2% | +7.7% | -0.6% | +0.8% | -0.6% | -0.2% | -0.5% |